Vitreous Levels of VEGF, IL-8, and TNF-α in Retinal Detachment

REFERENCES

• Haimann MH, Burton TC, Brown CK. Epidemiology of retinal detachment. Arch Ophthalmol 1982;100:289–292.
   PubMedGoogle Scholar
• Laatikainen L, Tolppanen EM, Harju H. Epidemiology of rhegmatogenous retinal detachment in a Finnish population. Acta Ophthalmol (Copenh) 1985;63:59–64.
   PubMed Web of Science ®Google Scholar
• Törnquist R, Stenkula S, Törnquist P. Retinal detachment. A study of a population-based patient material in Sweden 1971-1981. I. Epidemiology. Acta Ophthalmol (Copenh) 1987;65:213–222.
   PubMed Web of Science ®Google Scholar
• Sasaki K, Ideta H, Yonemoto J et al. Epidemiologic characteristics of rhegmatogenous retinal detachment in Kumamoto Japan. Graefes Arch Clin Exp Ophthalmol 1995;233:772–776.
   PubMed Web of Science ®Google Scholar
• Wong TY, Tielsch JM, Schein OD. Racial difference in the incidence of retinal detachment in Singapore. Arch Ophthalmol 1999;117:379–383.
   PubMedGoogle Scholar
• Ah-Fat FG, Sharma MC, Majid MA, McGalliard JN, Wong D. Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996. Br J Ophthalmol 1999;83:396–398.
   PubMed Web of Science ®Google Scholar
• Senger DR, Galli SJ, Dvorak AM et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983–985.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851–858.
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306–1309.
   PubMed Web of Science ®Google Scholar
• Tseng W, Cortez RT, Ramirez G, Stinnett S, Jaffe GJ. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol 2004;137:1105–1115.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Yoshida S, Khalil AK, Ishibashi T, Inomata H. Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci 1998;39:1097–1106.
   PubMed Web of Science ®Google Scholar
• Kramer M, Goldenberg-Cohen N, Axer-Siegel R et al. Inflammatory reaction in acute retinal artery occlusion: cytokine levels in aqueous humor and serum. Ocul Immunol Inflamm 2005;13:305–310.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487.
   PubMed Web of Science ®Google Scholar
• Lutty GA, McLeod DS, Merges C, Diggs A, Plouét J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996;114:971–977.
   PubMed Web of Science ®Google Scholar
• Yuuki T, Kanda T, Kimura Y et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complicat 2001;15:257–259.
   PubMed Web of Science ®Google Scholar
• Hernández C, Segura RM, Fonollosa A et al. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med 2005;22:719–722.
   PubMed Web of Science ®Google Scholar
• Armstrong D, Augustin AJ, Spengler R et al. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998;212:410–414.
   PubMed Web of Science ®Google Scholar
• Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:168–173.
   PubMed Web of Science ®Google Scholar
• Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH. Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 2001;42:1586–1591.
   PubMed Web of Science ®Google Scholar
• Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy]. Med Klin (Munich) 1995;90:134–137.
   Google Scholar
• Majka S, McGuire PG, Das A. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Invest Ophthalmol Vis Sci 2002;43:260–266.
   PubMedGoogle Scholar
• Yossuck P, Yan Y, Tadesse M, Higgins RD. Dexamethasone alters TNF-alpha expression in retinopathy. Mol Genet Metab 2001;72:164–167.
   PubMedGoogle Scholar
• Elner SG, Elner VM, Jaffe GJ et al. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995;14:1045–1053.
   PubMed Web of Science ®Google Scholar
• Rodriguez de la Rua E, Martinez V, Aragon J et al. Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study. Arch Soc Esp Oftalmol 2003;78:91–97.
   PubMedGoogle Scholar
• Asaria RH, Kon CH, Bunce C et al. How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology 2001;108:1184–1186.
   PubMed Web of Science ®Google Scholar
• Hooymans JM, De Lavalette VW, Oey AG. Formation of proliferative vitreoretinopathy in primary rhegmatogenous retinal detachment. Doc Ophthalmol 2000;100:39–42.
   Google Scholar
• Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998;17:77–98.
   PubMed Web of Science ®Google Scholar
• Cardillo JA, Stout JT, LaBree L et al. Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 1997;104:1166–1173.
   PubMed Web of Science ®Google Scholar
• Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 1997;115:237–241.
   PubMedGoogle Scholar
• Yanyali A, Bonnet M. [Risk factors of postoperative proliferative vitreoretinopathy in giant tears]. J Fr Ophtalmol 1996;19:175–180.
   Google Scholar
• Acar M, Ünlü N, Yılmaz G, Kocaoğlan H, Aslan B, Duman S. İleri evre proliferatif vitreoretinopatide vitreoretinal cerrahi sonucunu etkileyen faktörler. Türk Oftalmoloji Gazetesi 2002;32:510–515.
   Google Scholar